BLUE WATER BIOTECH INC (BWV) Stock Price, Forecast & Analysis
USA - NASDAQ:BWV - US09610B1089 - Common Stock
BWV Key Statistics, Chart & Performance
The current stock price of BWV is 0.1802 USD. In the past month the price decreased by -41.89%. In the past year, price decreased by -82.5%.
BWV Latest News, Press Relases and Analysis
BWV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.59 | 410.48B | ||
| AMGN | AMGEN INC | 15.4 | 181.29B | ||
| GILD | GILEAD SCIENCES INC | 15.26 | 155.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.18 | 112.08B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.41 | 73.50B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 880.71 | 58.88B | ||
| INSM | INSMED INC | N/A | 40.84B | ||
| NTRA | NATERA INC | N/A | 28.04B | ||
| BIIB | BIOGEN INC | 10.01 | 24.56B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.67 | 21.10B | ||
| INCY | INCYTE CORP | 16.22 | 20.34B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 34.66 | 14.37B |
Related stock screener links
About BWV
Company Profile
Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. The company is headquartered in Cincinnati, Ohio and currently employs 12 full-time employees. The company went IPO on 2022-02-18. The firm is focused on developing transformational therapies to address significant health challenges globally. The firm is engaged in developing a streptococcus pneumonia vaccine candidate, designed to specifically prevent highly infectious middle ear infections, known as acute otitis media (AOM), in children, and prevention of pneumonia in the elderly. The firm is also developing a universal flu vaccine that provides protection from all virulent strains in addition to licensing a norovirus (NoV) shell and protrusion (S&P) nanoparticle versatile virus-like particle (VLP) vaccine platform from Cincinnati Children’s Hospital Medical Center to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, among others. In addition, the Company is developing a Chlamydia vaccine candidate with the University of Texas Health Science Center in San Antonio (UT Health).
Company Info
BLUE WATER BIOTECH INC
201 E. Fifth Street, Suite 1900
Cincinnati OHIO US
Employees: 12
Phone: 15136204101
BLUE WATER BIOTECH INC / BWV FAQ
What does BLUE WATER BIOTECH INC do?
Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. The company is headquartered in Cincinnati, Ohio and currently employs 12 full-time employees. The company went IPO on 2022-02-18. The firm is focused on developing transformational therapies to address significant health challenges globally. The firm is engaged in developing a streptococcus pneumonia vaccine candidate, designed to specifically prevent highly infectious middle ear infections, known as acute otitis media (AOM), in children, and prevention of pneumonia in the elderly. The firm is also developing a universal flu vaccine that provides protection from all virulent strains in addition to licensing a norovirus (NoV) shell and protrusion (S&P) nanoparticle versatile virus-like particle (VLP) vaccine platform from Cincinnati Children’s Hospital Medical Center to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, among others. In addition, the Company is developing a Chlamydia vaccine candidate with the University of Texas Health Science Center in San Antonio (UT Health).
What is the stock price of BLUE WATER BIOTECH INC today?
The current stock price of BWV is 0.1802 USD. The price decreased by -5.16% in the last trading session.
What is the dividend status of BLUE WATER BIOTECH INC?
BWV does not pay a dividend.
How is the ChartMill rating for BLUE WATER BIOTECH INC?
BWV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the GICS sector and industry of BWV stock?
BLUE WATER BIOTECH INC (BWV) operates in the Health Care sector and the Biotechnology industry.
BWV Technical Analysis
BWV Financial Highlights
Over the last trailing twelve months BWV reported a non-GAAP Earnings per Share(EPS) of -0.86. The EPS decreased by -2.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -65.6% | ||
| ROE | -178.61% | ||
| Debt/Equity | 1.26 |
BWV Forecast & Estimates
8 analysts have analysed BWV and the average price target is 9.18 USD. This implies a price increase of 4994.34% is expected in the next year compared to the current price of 0.1802.